Records containing: Myositis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-09-21A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2026-07-24A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2026-04-27Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography
-
CLINICAL_TRIALS study record update · 2026-04-24Environmental Risk Factors for the Development of Myositis in Military Personnel
-
CLINICAL_TRIALS study record update · 2026-04-23A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2026-04-20Environmental Risk Factors for the Anti-Synthetase Syndrome
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
-
CLINICAL_TRIALS study record update · 2026-04-03Convenient Quantification of Myopathic Change in Muscle Via Electrical Impedance Myography
-
CLINICAL_TRIALS study record update · 2026-03-31Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
-
CLINICAL_TRIALS study record update · 2026-03-27Prospective Observational Study About Pregnancy and Medically Assisted Conception in Rare Diseases
-
CLINICAL_TRIALS study record update · 2026-03-17Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Pathophysiological Investigations of Systemic Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-27Treatment With add-on IVIg in Myositis Early In the diSease Course May be sUperior to Steroids Alone for Reaching CLinical improvemEnt
-
CLINICAL_TRIALS study record update · 2026-01-28MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) - A Qualitative Study of Patient-voiced Research Priorities Across Rare Myositis Diseases
-
CLINICAL_TRIALS study record update · 2025-12-24An Open-label Phase 2a Study to Evaluate the Safety and Efficacy of AlloNK®, an Allogeneic Cord Blood-derived NK Cell Therapy, in Combination With Rituximab in Relapsing Forms of B-cell Dependent Rheumatologic Diseases
-
CLINICAL_TRIALS study record update · 2025-12-17A Phase 1 Dose Evaluation Study of the Safety and Preliminary Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult Subjects With Refractory Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2025-11-24A Phase II Open-Label Study of Deucravacitinib for Refractory Adults With Dermatomyositis/ Juvenile Dermatomyositis
-
CLINICAL_TRIALS study record update · 2025-09-25A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis
-
CLINICAL_TRIALS study record update · 2025-09-16Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
-
CLINICAL_TRIALS study record update · 2025-07-23A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2025-05-13Multispectral Optoacustic Imaging in Patients With Myositis
-
CLINICAL_TRIALS study record update · 2025-04-03MYOPROSP: A Prospective Cohort Study to Identify a Stratified Approach in the Diagnosis, Treatment and Delivery of Care in Adult Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2025-02-18Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature
-
CLINICAL_TRIALS study record update · 2025-01-07A Randomized, Controlled Pilot Trial to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Treating Interstitial Lung Disease Associated With the Anti-synthetase Syndrome
-
CLINICAL_TRIALS study record update · 2024-09-19Investigation of the Validity, Reliability, and Responsiveness of the BETY-Biopsychosocial Questionnaire in Individuals Diagnosed with Myositis